Hirakawa K - Search Results

1

A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer.

Takashima T, Tokunaga S, Tei S, Nishimura S, Kawajiri H, Kashiwagi S, Yamagata S, Noda S, Nishimori T, Mizuyama Y, Sunami T, Tezuka K, Ikeda K, Ogawa Y, Onoda N, Ishikawa T, Kudoh S, Takada M, Hirakawa K. Takashima T, et al. Among authors: hirakawa k. Springerplus. 2016 Feb 24;5:164. doi: 10.1186/s40064-016-1833-1. eCollection 2016. Springerplus. 2016. PMID: 27026861 Free PMC article.

2

Prognostic value of combined analysis of estrogen receptor status and cellular proliferative activity in breast cancer patients with extensive lymph node metastases.

Takashima T, Onoda N, Ishikawa T, Ogawa Y, Kato Y, Fujimoto Y, Sowa M, Hirakawa K. Takashima T, et al. Among authors: hirakawa k. Oncol Rep. 2002 May-Jun;9(3):589-94. Oncol Rep. 2002. PMID: 11956633

3

Lymphangioma of the lesser omentum associated with abdominal esophageal carcinoma: report of a case.

Tezuka K, Ogawa Y, Satake K, Ohira M, Yamada S, Uno H, Wakasa K, Hirakawa K. Tezuka K, et al. Among authors: hirakawa k. Surg Today. 2002;32(4):362-6. doi: 10.1007/s005950200053. Surg Today. 2002. PMID: 12027204

4

Primary leiomyosarcoma of the breast: report of a case.

Shinto O, Yashiro M, Yamada N, Matsuoka T, Ohira M, Ishikawa T, Nishino H, Hirakawa K. Shinto O, et al. Among authors: hirakawa k. Surg Today. 2002;32(8):716-9. doi: 10.1007/s005950200133. Surg Today. 2002. PMID: 12181723 Review.

5

Thoracoscopic excision for ectopic mediastinal parathyroid tumor.

Ishikawa T, Onoda N, Ogawa Y, Takashima T, Matsunaga N, Michigami S, Okamura T, Tahara H, Inaba M, Nakatani T, Hirakawa K. Ishikawa T, et al. Among authors: hirakawa k. Biomed Pharmacother. 2002;56 Suppl 1:34s-36s. doi: 10.1016/s0753-3322(02)00211-1. Biomed Pharmacother. 2002. PMID: 12487248

6

Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells.

Chung SH, Onoda N, Ishikawa T, Ogisawa K, Takenaka C, Yano Y, Hato F, Hirakawa K. Chung SH, et al. Among authors: hirakawa k. Jpn J Cancer Res. 2002 Dec;93(12):1358-65. doi: 10.1111/j.1349-7006.2002.tb01245.x. Jpn J Cancer Res. 2002. PMID: 12495476 Free PMC article.

7

Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients.

Nakata B, Wang YQ, Yashiro M, Ohira M, Ishikawa T, Nishino H, Seki S, Hirakawa K. Nakata B, et al. Among authors: hirakawa k. Oncol Rep. 2003 Jul-Aug;10(4):997-1000. Oncol Rep. 2003. PMID: 12792759

8

Oral UFT and cyclophosphamide combination chemotherapy for metastatic breast cancer.

Ogawa Y, Ishikawa T, Chung SH, Ikeda K, Takashima T, Onoda N, Nakata B, Nishiguchi Y, Hirakawa K. Ogawa Y, et al. Among authors: hirakawa k. Anticancer Res. 2003 Jul-Aug;23(4):3453-7. Anticancer Res. 2003. PMID: 12926089 Clinical Trial.

9

Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.

Maeda K, Yashiro M, Nishihara T, Nishiguchi Y, Sawai M, Uchima K, Onoda N, Ohira M, Ishikawa T, Hirakawa K. Maeda K, et al. Among authors: hirakawa k. Surg Today. 2003;33(10):736-9. doi: 10.1007/s00595-003-2592-5. Surg Today. 2003. PMID: 14513319

10

Identification of a trypsinogen activity stimulating factor produced by pancreatic cancer cells: its role in tumor invasion and metastasis.

Uchima Y, Sawada T, Nishihara T, Umekawa T, Ohira M, Ishikawa T, Nishino H, Hirakawa K. Uchima Y, et al. Among authors: hirakawa k. Int J Mol Med. 2003 Dec;12(6):871-8. Int J Mol Med. 2003. PMID: 14612960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,475 results

Search Page

Filters